Neuraxpharm announces closing of acquisition of established products from Sanofi
DÜSSELDORF, Germany and BARCELONA, Spain, Feb. 1, 2023 /PRNewswire/ — Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous…